Phase 2 trial data (Jastreboff et al., NEJM 2023) demonstrated average weight reductions of approximately 1724% over 48 weeks notably higher than currently approved GLP-1 receptor agonists such as semaglutide, though direct comparisons are limited by differences in trial populations and designs
Artificial Color and Dye Free
It is better to verify with your insurance provider whether they cover the peptide therapy you have chosen
These injections contain a combination of essential nutrients, including methionine, inositol, choline, and B-vitamins, which work together to improve fat metabolism, reduce fat storage, and support overall wellness
Visible body composition changes typically emerge around week 3-4, with significant fat loss and waist circumference reduction becoming apparent by weeks 5-8